News

Artificial Intelligence (AI) bots have the potential to revolutionize laboratory and healthcare billing processes, creating significant improvements in efficiency, accuracy and cost-effectiveness. We explore their impact here through factual evidence such as referenced data or expert knowledge. Furthermore, we discuss anticipated trends over the next five years that may help shape their development further and…

Addiction to drugs is an epidemic that plagues societies worldwide, destroying lives and shattering families in its wake. While there are various approaches to dealing with addiction, combining Gospel-inspired teachings with evidence-based testing methods offers a holistic solution that may aid individuals in breaking free from its grips and breaking free of its chains. By…

Diagnostic laboratories play a crucial role in healthcare by providing accurate and timely diagnostic testing services. However, they face several challenges in the next five years that may impact their ability to provide high-quality services. One of the biggest challenges facing diagnostic laboratories is the increasing demand for testing. The COVID-19 pandemic has highlighted the…

Fentanyl is an opioid synthetic that is 50-100 times stronger than morphine and typically used to treat severe pain associated with cancer or surgery, but has recently become an illicit substance used by drug abusers in the US. Overdose deaths caused by illicit use have increased dramatically – according to the Centers for Disease Control…

The drug testing market has been steadily growing over the past few years due to various factors such as the increasing prevalence of drug abuse, strict government regulations, and the growing need for workplace drug testing. According to a report by MarketsandMarkets, the global drug testing market was valued at USD 4.86 billion in 2020…

As an independent laboratory, heliosDX is deeply committed to providing high-quality and affordable healthcare services to patients across the United States. However, we are increasingly concerned about the trend of insurance payers refusing to contract with independent laboratories, instead preferring to work exclusively with large big box laboratories like LabCorp or Quest. This trend is…

The opioid crisis has become one of the most pressing public health issues in the United States, with opioid-related overdose deaths reaching unprecedented levels in recent years. Healthcare providers have a critical role to play in addressing this crisis, and drug testing is an important tool that can help providers identify patients who may be…

DOWNLOAD PDF

DOWNLOAD PDF

DOWNLOAD PDF

DOWNLOAD PDF

DOWNLOAD PDF

DOWNLOAD PDF

DOWNLOAD PDF

ALPHARETTA, GA / ACCESSWIRE / October 19, 2021 / RushNet, Inc (OTC PINK:RSHN), (“the Company”) is pleased to announce that it’s subsidiary heliosDX has been invited to present at the Emerging Growth Conference on Wednesday October 27, 2021. heliosDX invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation…

Proin tellus mi, eleifend non venenatis sit amet, ullamcorper at ligula. Nunc molestie dolor nec magna fermentum in pharetra orci mollis. Nam tempor diam elit. Praesent magna metus, consequat consectetur viverra nec, convallis et lacus dolor amet!

ALPHARETTA, GA / ACCESSWIRE / August 26, 2021 / RushNet, Inc (OTC PINK:RSHN), (the “Company” or “heliosDX”) is pleased to announce through its subsidiary heliosDX the investment and adoption of Artificial Intelligence (“AI”) into the diagnostic laboratory. heliosDX signed an agreement to utilize Arkstone OneChoice® technology and reporting. The companies have been working to integrate the…

ALPHARETTA, GA / ACCESSWIRE / August 10, 2021 / RushNet, Inc (OTC PINK:RSHN), (“the Company”) with its subsidiary heliosDX is pleased to announce Aimee Matlock has been appointed to serve as the Director of Sales and Marketing for heliosDX. Mrs. Aimee Matlock joins heliosDX with 19 years of successful sales and marketing experience. The last nine…

ALPHARETTA, GA / ACCESSWIRE / July 28, 2021 / RushNet, Inc (OTC PINK:RSHN), (“the Company”) with its subsidiary heliosDX is pleased to announce Yann Gerville-Reache has been appointed to serve as the COO for heliosdX. Mr. Gerville-Reache will join the Executive Team in Orange Park, FL to assume the role of Chief Operations Officer. His experience…